ABSTRACT
Objective To investigate the mechanism of Chinese herbal medicine compound Tang Mai Ping (TMP) capsule to type 2 diabet in rats. Methods The models of type 2 diabetic rats were established by injecting lower dosage of streptozotocin (STZ, 35 mg/kg) to belly, and fed high sucrose and high fat diet. Modle rats were randomly divided into model group, TMP group, and Erjiashuanggu (EJS) group, at the same time normal control. The content of plasma insulin was detected by radio-immunicy, mRNA expressing of frame muscle of Glucose Transporter 4 (GluT4) gene was detected with hyvirdism in situ. Results After built model, levels of insulin were obviously ascended in rats, but the expression of GluT4 mRNA lower significantly (P
ABSTRACT
Aim To study antidiabetic effect and mechanism of Mogroside extracts(MGC) on hyperglycemic mice induced by Alloxan.Methods Alloxan-induced diabetic mice were fed with MGC at dose of 50,100?300,500 mg?kg~(-1) bw respectively for 30 d.The blood glucose levels,the blood lipid levels and antioxidation levels were assayed after the last fedding.Results ①MGC at dose of 100?300?500 mg?kg~(-1) bw significantly lowered the fasting blood glucose and the hypoglycemic effect of MGC at dose of 100 mg?kg~(-1) bw was the best ②MGC decreased the content of TC,TG and enhanced the content of HDL-C of alloxan-induced diabetic mice,so it could restore the blood lipid levels of diabetic mice(P0.01).Conclusion Mogroside extracts(MGC) have obvious glucose-lowering effect on hyperglycemic mice,its mechanism may be related with improving antioxidation level and restoring the blood lipid levels of hyperglycemic mice.
ABSTRACT
Objective To ev al uate the genotype distribution of the promoter of leptin gene in Chinese populat ion, and to verify its association with the plasma leptin level and anthropometr ic, metabolic and clinical parameters in type 2 diabetic patients and their non -diabetic first degree relatives. Methods Two hundred and sixty-nine patients with diabetes and 135 non-diabetic first degre e relatives in pedigrees of type 2 diabetes mellitus, and 85 normal controls wer e screened for presence of the polymorphism by PCR-RFLP assay, and body mass in dex (BMI), fasting plasma leptin, insulin, and glucose were measured and HOMA-I R determined. Results (1) In type 2 diabetes gr oup, AA genotype frequency (0.063) and A allele frequency (0.349) were higher th an those in normal controls (0.012 and 0.253, respectively). (2) Diabetic patien ts with AA or AC genotypes showed lower fasting leptin than those with CC genoty pe (P